Skip to content
Cas9
EntityQ16965677· pop 23· linked from 163 articles

Also known as SPy_1046, CRISPR-associated protein 9, CRISPR associated protein 9, Hypothetical protein SPy_1046, C

Cas9 (CRISPR-associated protein 9, formerly Cas5, Csn1, or Csx12) is a DNA cutting enzyme that is part of the CRISPR immune system in bacteria and archaea. It has been adapted to be used as a CRISPR genome editing tool that enables targeted modification of DNA sequences and permanently changes a cell’s genome.

Key facts

Nonhuman protein.Name
CRISPR-associated endonuclease Cas10
Nonhuman protein.image
Streptococcus pyogenes Cas9-DNA-RNA complex PDB 4OO8.png
Nonhuman protein.width
300px
Nonhuman protein.caption
S. pyogenes Cas9 in complex with sgRNA and its target DNA.
Nonhuman protein.Organism
Streptococcus pyogenes M1
Nonhuman protein.TaxID
301447
Nonhuman protein.Symbol
cas9
Nonhuman protein.AltSymbols
SpCas9
Nonhuman protein.EntrezGene
901176
Nonhuman protein.PDB
4OO8
Nonhuman protein.RefSeqmRNA
NC_002737.2
Nonhuman protein.RefSeqProtein
NP_269215.1
Nonhuman protein.UniProt
Q99ZW2
Nonhuman protein.ECnumber
3.1.-.-
Nonhuman protein.Chromosome
Genomic
Nonhuman protein.EntrezChromosome
NC_002737.2
Nonhuman protein.GenLoc_start
854134
Nonhuman protein.GenLoc_end
859472

via Wikipedia infobox

Protein · UniProt

CRISPR-associated endonuclease Cas9/Csn1

Gene
cas9
Organism
Streptococcus pyogenes serotype M1
Length
1,368 aa
Molecular mass
158,441 Da
Evidence
1: Evidence at protein level

CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids) (PubMed:21455174). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans-encoded small RNA (tracrRNA), endogenous ribonuclease 3 (rnc) and this protein. The tracrRNA serves…

3D-structureAntiviral defenseDNA-bindingEndonucleaseExonucleaseHydrolaseMagnesiumManganese
View on UniProt →

Swiss-Prot (reviewed) · via UniProt

Research

40,289 papers

via PubMed

Wikidata facts

Image
CRISPR-Cas9 Editing of the Genome (26453307604).jpg
Show 1 more fact
Sources (4)

via Wikidata · CC0

~32 min read

Encyclopedic overview

37 sections
Contents
  • History
  • Mechanism
  • Research
  • 2013
  • 2014
  • 2017-19
  • 2020
  • 2025
  • CRISPR-mediated immunity
  • Adaptation
  • CRISPR processing
  • Interference
  • Transcription regulation
  • Structural studies
  • Challenges in bacterial editing
  • Applications
  • Gene editing
  • Cellular defense
  • Gene regulation
  • CRISPR-mediated immunity
  • CRISPR-Cas defense stages
  • Adaptation
  • CRISPR processing/biogenesis
  • Interference/immunity
  • Transcription deactivation using dCas9
  • Structural and biochemical studies
  • Crystal structure
  • Interactions with sgRNA
  • DNA cleavage
  • Problems bacteria pose to Cas9 editing
  • Applications of Cas9 to transcription tuning
  • Interference of transcription by dCas9
  • Transcription activation by dCas9 fusion proteins
  • See also
  • References
  • Further reading
  • External links

Cas9 (CRISPR-associated protein 9, formerly Cas5, Csn1, or Csx12) is a DNA cutting enzyme that is part of the CRISPR immune system in bacteria and archaea. It has been adapted to be used as a CRISPR genome editing tool that enables targeted modification of DNA sequences and permanently changes a cell’s genome.

The CRISPR-Cas9 system is widely used in genetic engineering, medicine, agriculture, and biotechnology. Cas9 introduces site-specific double-stranded breaks in DNA, enabling gene inactivation, removal, or insertion through cellular repair mechanisms such as non-homologous end joining or homologous recombination. Variants of Cas9, including Cas9 nickase (Cas9n), that create single-strand breaks, and versions recognizing different PAM sequences, have been developed to address limitations in CRISPR-Cas9 editing.

Excerpted from Wikipedia’s “Cas9” article, available under the CC BY-SA 4.0 licence.

Gallery (6)